Novartis Beats Failure-To-Warn Suit Over Zometa, Jury Rules
Novartis Pharmaceuticals Corp. defeated a cancer patient's claims that she suffered a jaw disease after taking its cancer therapy drug Zometa when a California federal jury found that the drugmaker was...To view the full article, register now.
Already a subscriber? Click here to view full article